Longeveron(LGVN) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update MIAMI, August 13, 2025 -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial results for the quarter ended June 30, 2025 and provided a business update. "Our differentiated approach to stem cell therapy continues to yield positive results ...